Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongbing Zhang

Showing results (221-230 of 269) with videos related to

Pageof 27
Sort By:
Cell Death & Disease|September 4, 2024
L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinomaZihe Zhang, Yongwen Li, Ruifeng Shi, et al.
Biochemical Pharmacology|March 27, 2025
xCT/Slc7a11 promotes pulmonary arterial hypertension by disrupting AMPKα suppression of mTOR activationYan Meng, Cuiting Zheng, Xiyu Zhang, et al.
The Journal of Experimental Medicine|September 25, 2025
RIPK1 S161 phosphorylation promotes further autophosphorylation and cecal necroptosis in TNF-treated miceTao Han, Chenchen Ruan, Huiyong Lin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|January 20, 2024
Active AKT2 stimulation of SREBP1/SCD1-mediated lipid metabolism boosts hepatosteatosis and cancerFuqiang Huang, Na Zhao, Pei Cai, et al.
Nature Communications|September 2, 2014
TSC1 controls macrophage polarization to prevent inflammatory diseaseLinnan Zhu, Tao Yang, Longjie Li, et al.
Pediatric Research|September 7, 2018
Time-restricted feeding causes irreversible metabolic disorders and gut microbiota shift in pediatric miceDandan Hu, Yilei Mao, Gang Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2022
Oncogenic β-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancerFangming Liu, Xiaochen Gai, Yuting Wu, et al.
Acta Pharmaceutica Sinica. B|October 22, 2020
Transporters (OATs and OATPs) contribute to illustrate the mechanism of medicinal compatibility of ingredients with different properties in yuanhuzhitong prescriptionZe Wang, Haihua Shang, Yazhuo Li, et al.
Biomaterials|September 1, 2022
Functional imaging and targeted drug delivery in mice and patient tumors with a cell nucleolus-localizing and tumor-targeting peptideRenwei Jing, Qian Wang, Lu Chen, et al.
Cell Death & Disease|February 11, 2021
AKT1-CREB stimulation of PDGFRα expression is pivotal for PTEN deficient tumor developmentXiaofeng Wan, Meng Zhou, Fuqiang Huang, et al.
Pageof 27

Showing results (221-230 of 269) with videos related to

Sort By:
Pageof 27
Cell Death & Disease|September 4, 2024
L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinomaZihe Zhang, Yongwen Li, Ruifeng Shi, et al.
Biochemical Pharmacology|March 27, 2025
xCT/Slc7a11 promotes pulmonary arterial hypertension by disrupting AMPKα suppression of mTOR activationYan Meng, Cuiting Zheng, Xiyu Zhang, et al.
The Journal of Experimental Medicine|September 25, 2025
RIPK1 S161 phosphorylation promotes further autophosphorylation and cecal necroptosis in TNF-treated miceTao Han, Chenchen Ruan, Huiyong Lin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|January 20, 2024
Active AKT2 stimulation of SREBP1/SCD1-mediated lipid metabolism boosts hepatosteatosis and cancerFuqiang Huang, Na Zhao, Pei Cai, et al.
Nature Communications|September 2, 2014
TSC1 controls macrophage polarization to prevent inflammatory diseaseLinnan Zhu, Tao Yang, Longjie Li, et al.
Pediatric Research|September 7, 2018
Time-restricted feeding causes irreversible metabolic disorders and gut microbiota shift in pediatric miceDandan Hu, Yilei Mao, Gang Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2022
Oncogenic β-catenin stimulation of AKT2-CAD-mediated pyrimidine synthesis is targetable vulnerability in liver cancerFangming Liu, Xiaochen Gai, Yuting Wu, et al.
Acta Pharmaceutica Sinica. B|October 22, 2020
Transporters (OATs and OATPs) contribute to illustrate the mechanism of medicinal compatibility of ingredients with different properties in yuanhuzhitong prescriptionZe Wang, Haihua Shang, Yazhuo Li, et al.
Biomaterials|September 1, 2022
Functional imaging and targeted drug delivery in mice and patient tumors with a cell nucleolus-localizing and tumor-targeting peptideRenwei Jing, Qian Wang, Lu Chen, et al.
Cell Death & Disease|February 11, 2021
AKT1-CREB stimulation of PDGFRα expression is pivotal for PTEN deficient tumor developmentXiaofeng Wan, Meng Zhou, Fuqiang Huang, et al.
Pageof 27